vaccine technologies

vaccine technologies

vaccine technologies and types of vaccine treatments have been improving. This channel tracks news and blogs about advances in vaccine production, types of vaccines, and the companies that manufacture vaccines.

US - Vical has announced a breakthrough for pandemic influenza DNA vaccines following preliminary human data.  
From thepoultrysite.com ()
More perspectives...
Vical Incorporated announced a breakthrough with preliminary clinical trial data demonstrating that DNA vaccines can safely achieve significant immune responses against H5N1 pandemic influenza in humans.  
From news.search.yahoo.com via Yahoo News. ()
Related news:
More perspectives...
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery ...  
From news.google.com via Google News. ()
More perspectives...
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced recently pre-clinical results from two proprietary plasmid DNA-based universal influenza vaccine candidates using the company's...  
From news.search.yahoo.com via Yahoo News. ()
Related news:
More perspectives...
Inovio Biomedical Corporation , a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced recently pre-clinical results from two proprietary ...  
From rss.topix.net via Topix. ()
More perspectives...
PORTLAND, Ore.----Bioject Medical Technologies Inc. , a leading developer of needle-free injection therapy systems, today announced that the Biojector® 2000 was used in Vical Inc.'s first Phase 1 human trial of H5N1 pandemic influenza DNA vaccines formulated with Vical's Vaxfectin® adjuvant...  
From news.search.yahoo.com via Yahoo News. ()
More perspectives...
SAN DIEGO----Inovio Biomedical Corporation , a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today that the Company has been invited to present at the following upcoming scientific conferences: Controlled Release...  
From news.search.yahoo.com via Yahoo News. ()
More perspectives...
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim results from its ongoing phase I/II clinical study of its ChronVac-C® therapeutic DNA...  
From news.search.yahoo.com via Yahoo News. ()
More perspectives...
Sorted by: Top Picks
Written by kerwood on
 
Written by ioman01 on
 
Written by ioman01 on
 
Written by ioman01 on
 
Written by javari78 on
 
Written by KeithConnects on
 
Written by ioman01 on
 
Sponsors
Sorted by: Top Rated
  1
  2
  3
  4
  5
  6

More From Zimbio
Copyright © 2008 - Zimbio, Inc. Some rights reserved.